The risk of pancreatic cancer is 1–3% in patients with a BRCA1 mutation and 3–5% by the age of 70 years in patients with a BRCA2 mutation as compared to the general population with a risk of 0.5% [27,30]. This evidence concerns the gene BRCA2 and pancreatic neoplasm.